(Q40779648)

23 September 2017

1 reference

title

Neurotrophic strategies for treating Alzheimer's disease: lessons from basic neurobiology and animal models (English)

1 reference

23 September 2017

0 references

Richard E Clatterbuck

3

object named as

Clatterbuck RE

1 reference

23 September 2017

Koliatsos VE

1

1 reference

23 September 2017

Price DL

2

1 reference

23 September 2017

Markowska AL

4

1 reference

23 September 2017

Olton DS

5

1 reference

23 September 2017

Wilcox BJ

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

Annals of the New York Academy of Sciences

23 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 September 2017

volume

695

1 reference

23 September 2017

page(s)

292-299

1 reference

The amyloid proteins of Alzheimer's disease as potential targets for drug therapy

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Cytokines in neural regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Choline acetyltransferase messenger RNA expression in developing and adult rat brain: regulation by nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Neurotrophin-3: a neurotrophic factor related to NGF and BDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Potential use of nerve growth factor to treat Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

Neuronal degeneration in human diseases and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB23069.X

10.1111/J.1749-6632.1993.TB23069.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference